Publicacions (66) Publicacions en què ha participat algun/a investigador/a

2013

  1. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 60, Núm. 5

  2. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Medicina Intensiva, Vol. 37, Núm. 4, pp. 259-283

  3. 2013: Documento «sevilla» de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica

    Farmacia Hospitalaria, Vol. 37, Núm. 3, pp. 209-235

  4. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

    Leukemia, Vol. 27, Núm. 10, pp. 2056-2061

  5. Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms

    Haematologica, Vol. 98, Núm. 9, pp. 1414-1420

  6. Adipose tissue-derived mesenchymal stem cells: Isolation, expansion, and characterization

    Methods in Molecular Biology, Vol. 1036, pp. 47-61

  7. Adipose-derived stem cells combined with Neuregulin-1 delivery systems for heart tissue engineering

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 1, pp. 143-150

  8. Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study

    Thrombosis Research, Vol. 132, Núm. 6, pp. 666-670

  9. Advances in the field of tissue engineering and regenerative medicine: State of the art and regulatory issues

    Journal of Biomaterials and Tissue Engineering, Vol. 3, Núm. 3, pp. 245-260

  10. Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry

    Haematologica, Vol. 98, Núm. 1, pp. 79-86

  11. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein

    Cancer Research, Vol. 73, Núm. 1, pp. 139-149

  12. Análisis de las alteraciones epigenéticas en pacientes con leucemia aguda linfoblastica

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 1, pp. 178-179

  13. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 665-672

  14. Biomimetic hydroxyapatite coating on pore walls improves osteointegration of poly(L-lactic acid) scaffolds

    Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 101 B, Núm. 1, pp. 173-186

  15. Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model

    Diabetologia, Vol. 56, Núm. 4, pp. 838-846

  16. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group

    Annals of Hematology, Vol. 92, Núm. 9, pp. 1151-1179

  17. Culture of human bone marrow-derived mesenchymal stem cells on of poly(l-lactic acid) scaffolds: Potential application for the tissue engineering of cartilage

    Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 21, Núm. 8, pp. 1737-1750

  18. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells

    Haematologica, Vol. 98, Núm. 2, pp. 279-287

  19. Cytokines for the treatment of gastrointestinal cancers: Clinical experience and new perspectives

    Expert Opinion on Investigational Drugs, Vol. 22, Núm. 7, pp. 827-841

  20. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598